BIOMAT Database Logo BIOMAT Database Logo

Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. 2009

Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver, Colorado 80206, USA. mrozp@njhealth.org

BACKGROUND Workplace surveillance identifies chronic beryllium disease (CBD) but it remains unknown over what time frame mild CBD will progress to a more severe form. METHODS We examined physiology and treatment in 229 beryllium sensitization (BeS) and 171 CBD surveillance-identified cases diagnosed from 1982 to 2002. Never smoking CBD cases (81) were compared to never smoking BeS patients (83) to assess disease progression. We compared CBD machinists to non-machinists to examine effects of exposure. RESULTS At baseline, CBD and BeS cases did not differ significantly in exposure time or physiology. CBD patients were more likely to have machined beryllium. Of CBD cases, 19.3% went on to require oral immunosuppressive therapy. At 30 years from first exposure, measures of gas exchange were significantly worse and total lung capacity was lower for CBD subjects. Machinists had faster disease progression as measured by pulmonary function testing and gas exchange. CONCLUSIONS Medical surveillance for CBD identifies individuals at significant risk of disease progression and impairment with sufficient time since first exposure.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D003120 Colorado State bounded on the north by Wyoming and Nebraska, on the east by Kansas and Nebraska, on the south by New Mexico and Oklahoma, and on the west by Utah.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
November 2004, American journal of industrial medicine,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Significance of the blood beryllium lymphocyte proliferation test.
October 1996, Environmental health perspectives,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Identification of an abnormal beryllium lymphocyte proliferation test.
February 2003, Toxicology,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
May 2001, Applied occupational and environmental hygiene,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Screening blood test identifies subclinical beryllium disease.
July 1989, Journal of occupational medicine. : official publication of the Industrial Medical Association,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Statistical methods for the blood beryllium lymphocyte proliferation test.
October 1996, Environmental health perspectives,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
October 2004, American journal of respiratory cell and molecular biology,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing.
January 1996, International archives of occupational and environmental health,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program.
November 2007, International archives of occupational and environmental health,
Margaret M Mroz, and Lisa A Maier, and Matthew Strand, and Lori Silviera, and Lee S Newman
Use of the Beryllium Lymphocyte Proliferation Test (BeLPT) for screening.
April 2007, Journal of occupational and environmental medicine,
Copied contents to your clipboard!